TruBridge

TruBridge Elects Amy O’Keefe to the Company’s Board of Directors

New Director Brings Deep Financial and Operational Expertise October 21, 2024 – MOBILE, Ala.- TruBridge, Inc. (“TruBridge” or the “Company”) (NASDAQ:TBRG), a healthcare solutions company, today announced the election of Amy O’Keefe to its Board of Directors (the “Board”), effective October 18, 2024. “Amy’s deep financial experience and public company leadership spanning over three decades will be invaluable to TruBridge as we execute our growth … Continue reading TruBridge Elects Amy O’Keefe to the Company’s Board of Directors

Gruppo San Donato

Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

The new company envisages the development of a network that will include a hundred structures by 2030 and will be chaired by Vito Cozzoli and led by CEO Bonifacio Moroni Press Release – The closing of the strategic agreement between San Donato Group, GKSD e Generali Italy: born Smart Clinic SpA, The company joint venture which aims to create, by 2030, a network of approximately 100 healthcare facilities across the entire Italian territory. … Continue reading Smart Clinic SpA is born: a joint venture between Gruppo San Donato, GKSD and Generali Italia for the health of the future 

Alpha Cognition

Alpha Cognition Announces Appointment of VP Finance and Accounting

October 21, 2024 – VANCOUVER, British Columbia – Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF)(“Alpha Cognition” or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, announces that Henry Du has joined Alpha Cognition as the VP of Finance and Accounting and interim Chief Financial Officer (CFO). “I am excited to join Alpha Cognition at such a critical juncture” Post … Continue reading Alpha Cognition Announces Appointment of VP Finance and Accounting

Vianautis

ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer

ViaNautis Bio (“ViaNautis” or the “Company”), a groundbreaking nanomedicine company at the forefront of genetic therapies, today announces the appointment of Dr Adi Hoess as Chief Executive Officer of ViaNautis. He will succeed Co-Founder and CEO Dr Francesca Crawford who has been stepping down from her role. Dr Adi Hoess brings a wealth of experience to ViaNautis, having previously served as CEO of Nasdaq-listed German … Continue reading ViaNautis Bio appoints Dr Adi Hoess as Chief Executive Officer

CVS Health

CVS Health Appoints David Joyner President and Chief Executive Officer

October 18, 2024 Roger Farah Named Executive Chairman of the Board Company provides preliminary guidance for third quarter 2024 GAAP diluted Earnings per Share (EPS) of $0.03 to $0.08 and Adjusted EPS of $1.05 to $1.10 WOONSOCKET, RI (October 18, 2024) – CVS Health (NYSE: CVS) today announced that David Joyner was appointed President and Chief Executive Officer, effective October 17, replacing Karen Lynch, who stepped … Continue reading CVS Health Appoints David Joyner President and Chief Executive Officer

The Health and Environment Alliance

Health groups welcome the confirmation of revised EU air quality law: milestone for public health

Press release – 14th October 2024 Today, the EU Environment Ministers confirmed the revised Ambient Air Quality Directive, which was agreed in trilogue in February 2024. The revised legislation updates limits for key air pollutants in the EU to align more closely with the latest World Health Organization (WHO) recommendations, and to reflect the serious health impacts of air pollution. The Health and Environment Alliance welcomes … Continue reading Health groups welcome the confirmation of revised EU air quality law: milestone for public health

Sanofi

Sanofi and Orano join forces to develop next-generationradioligand medicines

Press Release – Paris, October 17, 2024. Sanofi and Orano Med, a subsidiary of the Orano Group and a pioneer in the development of targeted alphatherapies in oncology, have entered into an agreement to combine their expertise in the fight against rare cancers and further accelerate the development of next-generation radioligand medicines. Building on the expertise and radioligand pipeline of Orano Med, Sanofi and Orano will … Continue reading Sanofi and Orano join forces to develop next-generationradioligand medicines

NSF Welcomes Mel Cash as Chief Commercial Officer

NSF Welcomes Mel Cash as Chief Commercial Officer

October 14, 2024 Global public health and safety organization announces new Commercial lead to drive growth and innovation. ANN ARBOR, Mich – NSF, a leading global public health and safety organization, has named Melissa (Mel) Cash its Vice President and Chief Commercial Officer. In this role, Cash will be responsible for accelerating growth across NSF’s global markets through commercial go-to-market strategies, sales enablement, brand awareness, program … Continue reading NSF Welcomes Mel Cash as Chief Commercial Officer